AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2580180
Drug: Captopril and
RxNorm normalized name: captopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril and Hydrochlorothiazide (long-term treatment, 11 months)
Trial: 22571225
Drug: Non-surgical debridement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical debridement without systemic antibiotics
Trial: 20685496
Drug: Ibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen 200 mg/Paracetamol 500 mg
Trial: 18394014
Drug: Low-dose HT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose HT (1 mg of 17beta-estradiol and 0.5 mg of NETA)
Trial: 3882657
Drug: Erythromycin stearate,
RxNorm normalized name: Erythromycin Stearate, stearate 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate, 1.5 g, administered orally 1 hour before extraction
Trial: 11768839
Drug: Oral tolterodine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tolterodine 2 mg BID (on days 1-14)
Trial: 9244152
Drug: AM‐C10 (ampicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM‐C10 (ampicillin suppositories with sodium caprate)
Trial: 9244152
Drug: AM (ampicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM (ampicillin suppositories without sodium caprate)
Trial: 29973307
Drug: Incentive (intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incentive (intervention plus incentive; CAD $5.00 e‐gift card delivered weekly for completing action plans over 4 weeks)
Trial: 8775589
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (encainide or flecainide)
Trial: 1295821
Drug: GH regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH regimen of 25 IU/m2/week administered as a daily subcutaneous injection (16 short normal children, 9 males, 7 females)
Trial: 31390305
Drug: Kinect-based educational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kinect-based educational games (Fruits) played once a week for 5 weeks in addition to standard treatment
Trial: 28690041
Drug: IV acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV acetaminophen (1 g IV)
Trial: 28690041
Drug: Oral acetaminophen
RxNorm normalized name: acetaminophen Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetaminophen (1 g oral)
Trial: 28690041
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral placebo and volume-matched IV normal saline)
Trial: 21484454
Drug: Photogem® gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photogem® gel 50 mg/l (P50G)
Trial: 21484454
Drug: Photogem® gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photogem® gel 100 mg/l (P100G)
Trial: 4014185
Drug: Interviewer-administered questionnaire
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-administered questionnaire
Trial: 25336165
Drug: Parenteral cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parenteral cefazolin
Trial: 25336165
Drug: Oral cefalexin
RxNorm normalized name: cephalexin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cefalexin
Trial: 19615131
Drug: Xuebijing injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuebijing injection (100 ml twice a day for 7 days)
Trial: 17524720
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (nitrogen and >or=10 kcal/kg/day of non‐protein calories for >or=5 days)
Trial: 9521635
Drug: Isoflavonoids (55
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavonoids (55 mg daily, predominantly genistein)
Trial: 28445783
Drug: Traditional SMA
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional SMA group focusing on medication management and self‐management counseling
Trial: 25619124
Drug: Tamoxifen 10mg
RxNorm normalized name: TAMOXIFEN 10MG/5ML SOLN,ORAL
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10mg daily for 12 weeks
Trial: 23933145
Drug: Nicotine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (4 mg) given as nicotine gum
Trial: 21035560
Drug: Salmeterol 25
RxNorm normalized name: fluticasone-salmeterol 250 mcg-50 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 25 μg
Trial: 20856830
Drug: Salbutamol 200
RxNorm normalized name: Salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol 200 μg
Trial: 18302293
Drug: Prophylactic lamivudine
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Prophylactic lamivudine treatment
Trial: 12697482
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia (PCBPA) with a mixture of 1% lidocaine and 0.25% bupivacaine, basal infusion of 2 ml/h, bolus dose of 3 ml, lockout time of 45 min.
Trial: 10321416
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 8 mg once daily for 4 weeks, followed by 16 mg once daily for 4 weeks
Trial: 10321416
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 8 mg twice daily for 4 weeks
Trial: 10321416
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (once and twice daily)
Trial: 10321416
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (once daily)
Trial: 7050717
Drug: Surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery plus chemotherapy with dacarbazine
Trial: 26178726
Drug: C8-dietary oil
RxNorm normalized name: C8:0
DrugBank: Caprylic acid (DB04519)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C8-dietary oil (13.15 g)
Trial: 26178726
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (19 g)
Trial: 26178726
Drug: Tributyrin (6.53
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tributyrin (6.53 g)
Trial: 24646528
Drug: Amoxicillin/clavulanate (antibiotics)
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (antibiotics)
Trial: 10695392
Drug: Conventional dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dose prednisolone (1.0 mg/kg/day)
Trial: 4028963
Drug: Subcutaneous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous epinephrine (E) 0.3 mg sub-Q q20min (max 0.9 mg)
Trial: 4028963
Drug: Subcutaneous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous epinephrine (E)
Trial: 30535090
Drug: Sucralose consumption
RxNorm normalized name: Sucralose
DrugBank: Sucralose (DB15049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralose consumption (15% of Acceptable Daily Intake every day for 14 days)
Trial: 16119515
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg tablets (test formulation)
Trial: 16119515
Drug: Klaricid (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Klaricid (reference formulation)
Trial: 8055292
Drug: Unilateral electroconvulsive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral electroconvulsive therapy (U‐ECT) with nondominant long-distance parietotemporal electrode placement
Trial: 8055292
Drug: Bilateral bitemporal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral bitemporal electroconvulsive therapy (ECT)
Trial: 3341801
Drug: Potent topically
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potent topically administered steroids
Trial: 4177135
Drug: Rh-immune globulin
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rh-immune globulin administered at delivery
Trial: 11244765
Drug: roxatidine acetate
RxNorm normalized name: roxatidine acetate
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxatidine acetate hydrochloride 150 mg
Trial: 29682294
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard treatment)
Trial: 23469662
Drug: Transperineal ultrasonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transperineal ultrasonic therapy
Trial: 14665549
Drug: Alfentanil 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 15 micro g kg(‐1) h(‐1) + Propofol 6 mg kg(‐1) h(‐1)
Trial: 14665549
Drug: Alfentanil 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 15 micro g kg(‐1) h(‐1) + Propofol 3 mg kg(‐1) h(‐1)
Trial: 14665549
Drug: Vertex‐inion electrode
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vertex‐inion electrode site after 30 min of propofol infusion
Trial: 8238130
Drug: Antibiotics (ampicillin‐amoxicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (ampicillin‐amoxicillin and erythromycin)
Trial: 3120568
Drug: High nitrogen
RxNorm normalized name: Isosource High Nitrogen Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High nitrogen diet (366 mg N/(kg.d))
Trial: 3120568
Drug: Low nitrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low nitrogen diet (191 mg N/(kg.d))
Trial: 24989946
Drug: Abediterol 10
RxNorm normalized name: Abediterol
DrugBank: Abediterol (DB12100)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 10 µg
Trial: 24989946
Drug: Abediterol 25
RxNorm normalized name: Abediterol
DrugBank: Abediterol (DB12100)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 25 µg
Trial: 24989946
Drug: Abediterol 50
RxNorm normalized name: Abediterol
DrugBank: Abediterol (DB12100)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 50 µg
Trial: 1961960
Drug: Thiopental for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental for intravenous induction with oxygen/nitrous oxide (30/70%) for maintenance (group I)
Trial: 7013978
Drug: BCNU or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCNU or methyl-CCNU chemotherapy without radiotherapy (Category A)
Trial: 7013978
Drug: Whole-brain radiation
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-brain radiation treatment (6000 rad) with surgery (Category B)
Trial: 15385223
Drug: Disulfiram (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disulfiram (200 mg daily)
Trial: 24117666
Drug: Adjunctive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive therapy (mailed letters emphasizing harmful effects of alcohol)
Trial: 19950569
Drug: Insulin Aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin Aspart (IAsp) with NPH
Trial: 19950569
Drug: Human Insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human Insulin (HI) with NPH
Trial: 2257065
Drug: TXA2 synthesis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA2 synthesis inhibitor, anisodamine
Trial: 25781977
Drug: Increased dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dose (800 mg albendazole) annually for 24 months (H1)
Trial: 20095375
Drug: Interferon alpha‐2b,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha‐2b, 3 million IU, administered rectally on chemotherapy days (twice weekly) for 4 months or more
Trial: 17119538
Drug: Farampator (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Farampator (500 mg)
Trial: 9150314
Drug: IL-10 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-10 treatment in co-cultures with AMs from healthy volunteers
Trial: 9150314
Drug: IL-10 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-10 treatment in co-cultures with AMs from patients with IPF
Trial: 28455085
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen 1000 mg every 8 hours for 48 hours (total of 6 doses)
Trial: 21164304
Drug: Intravenous sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sedation (IVS)
Trial: 23192781
Drug: Gadoxetate disodium
RxNorm normalized name: Gadoxetate Disodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gadoxetate disodium (10 mL, n = 97; 8 mL, n = 1; 16 mL, n = 1)
Trial: 23192781
Drug: Gadobenate dimeglumine
RxNorm normalized name: Gadobenate Dimeglumine
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gadobenate dimeglumine (0.1 mmol per kilogram of body weight, maximum dose, 20 mL)
Trial: 18503218
Drug: L-carnitine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine supplementation (10 mg/kg orally, 3 times per week for 12 months)
Trial: 15904591
Drug: Intraincisional (II)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraincisional (II) instillation of 25 mg of bupivacaine
Trial: 12580839
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 100-150 mg/day for five days starting from day 2 of the cycle and 150 IU of hMG/day on days 6-10, GnRH antagonist (Centrorelix) 0.25 mg/day started when the leading follicle reached 16 mm in the absence of an LH surge
Trial: 498828
Drug: Quinidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (200 mg every six hours)
Trial: 28511669
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg once daily for 12 months
Trial: 19289710
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray, 200 microg once daily
Trial: 17021664
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (laser instrument switched off) applied over the same protocol as the intervention group
Trial: 11515948
Drug: Labial infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labial infiltration of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine
Trial: 11515948
Drug: Labial infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labial infiltration of 1.8 mL of 2% lidocaine with 1:50,000 epinephrine
Trial: 8908388
Drug: UAE (Urinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UAE (Urinary Albumin Excretion)
Trial: 27865590
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection (100 units of Botox)
Trial: 21247664
Drug: Aquaphor Healing
RxNorm normalized name: Aquaphor Healing
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aquaphor Healing Ointment (AHO)
Trial: 21651908
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sildenafil citrate
Trial: 12722035
Drug: Dual-dialyzer therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-dialyzer therapy
Trial: 8528039
Drug: Active 22
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active 22 mg nicotine patches
Trial: 7324833
Drug: buprenorphine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buprenorphine (0.3 mg)
Trial: 1675119
Drug: oxymorphone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oxymorphone (1 mg)
Trial: 23424061
Drug: Continuous theta
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous theta burst stimulation (cTBS), 5 daily sessions
Trial: 12761725
Drug: Biofeedback therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback therapy
Trial: 15376398
Drug: Jia Wei
RxNorm normalized name: Ci Wu Jia
DrugBank: Eleuthero (DB14303)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jia Wei Si Jun Zi Tang (JWSJZT) + regular protective therapy
Trial: 15376398
Drug: Regular protective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular protective therapy
Trial: 9356538
Drug: High-protein diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein diet (2.1 g/kg)
Trial: 9356538
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.7 g/kg)
Trial: 31668666
Drug: Intraosseous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraosseous dexamethasone injection (4 mg)
Trial: 31668666
Drug: Submucosal dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Submucosal dexamethasone injection
Trial: 31668666
Drug: Both techniques
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both techniques of dexamethasone injection
Trial: 21359646
Drug: Oral rivaroxaban
RxNorm normalized name: Rivaroxaban
DrugBank: Rivaroxaban (DB06228)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral rivaroxaban 10 mg once daily for 35 ± 4 days
Trial: 10709776
Drug: Fluconazole (≥
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (≥ 200 mg/day)
Trial: 14668578
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg twice daily
Trial: 28628884
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (specifics not provided)
Trial: 25419594
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of TB and SBA
Trial: 8567141
Drug: Ultrasonographic monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ultrasonographic monitoring of preoperative chemotherapy
Trial: 2560470
Drug: CY 216
RxNorm normalized name: Cys
DrugBank: Cysteine (DB00151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CY 216 (7,500 anti-Xa units I.C. daily subcutaneous injection)
Trial: 28234826
Drug: Round silicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Round silicone implant
Trial: 28234826
Drug: Both anatomical
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both anatomical and round implants
Trial: 21150631
Drug: Caudal clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caudal clonidine 1 μg kg⁻¹ with 0.25% bupivacaine (0.75 ml kg⁻¹)
Trial: 6507309
Drug: Pindolol (small
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (small dose)
Trial: 6507309
Drug: Pindolol (large
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (large dose)
Trial: 24717460
Drug: Continuous renal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous renal replacement therapy commencement ≥ 46.0 hours
Trial: 21952978
Drug: Tofacitinib 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 3 mg twice a day
Trial: 23294500
Drug: Tofacitinib 10
RxNorm normalized name: tofacitinib 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 10 mg twice a day
Trial: 21952978
Drug: Tofacitinib 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 15 mg twice a day
Trial: 10989239
Drug: Lumbar spine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar spine BMD greater than 1.20 g/cm(2) (or 2.5 S.D. above the mean)
Trial: 10989239
Drug: Each 0.1
RxNorm normalized name: PEACH 0.1 g in 1 mL INTRADERMAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Each 0.1 g/cm(2) increase in lumbar spine BMD
Trial: 10989239
Drug: Each 0.1
RxNorm normalized name: PEACH 0.1 g in 1 mL INTRADERMAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Each 0.1 g/cm(2) increase in femoral neck BMD
Trial: 10989239
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy in osteoporotic women
Trial: 27165014
Drug: Amitriptyline 25
RxNorm normalized name: amitriptyline 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 25 mg
Trial: 9411906
Drug: Amitriptyline 10
RxNorm normalized name: amitriptyline 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 10 mg